Eisai: 18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer's Disease
- Written by ACN Newswire - Press Releases
Read more //?#
.
Popular
Exploring the Benefits of Fee Funding
There comes a time in everybody’s life when we need professional help. Dealing with an accountant or commercial lawyer is often the best way to protect your interests, but paying your invoice may be a challenge. Working with ...
Looming compensation danger faces business as people continue to work from home
A human resources consultancy is warning that, with a massive increase in the number of employees working from home, business owners may become liable for thousands of dollars in compensation claims around physical and menta...
Are you paying too much for your car insurance?
Car insurance is an important part of driving, but not all policies are created equally. You may be overpaying for your current insurance policy, especially if your lifestyle circumstances, such as age and those driving the car...
